GeneDx Holdings Corp. announced that on April 24, 2023, Rachel Sherman and Dennis Charney notified the Board that they will not stand for re-election as directors of the Company at the Company's 2023 annual meeting of stockholders (the 2023 Annual Meeting) and will continue to serve as directors of the Company until the 2023 Annual Meeting . There are no disagreements between Dr. Sherman or Dr. Charney and the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.6 USD | +4.46% | -7.99% | +649.09% |
04-30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
04-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+649.09% | 539M | |
-23.92% | 7.86B | |
+1.09% | 2.63B | |
-8.06% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.18% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B | |
+15.72% | 957M |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Announces Rachel Sherman and Dennis Charney Notifies the Board That They Will Not Stand for Re-Election as Directors